Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: A review

被引：18

作者：

Ammar Hassanzadeh Keshteli ^{[1
]}

Vickie E Baracos ^{[2
]}

Karen L Madsen ^{[1
]}

机构：

[1] Department of Medicine,University of Alberta,Edmonton,Alberta T6G 2E1,Canada

[2] Department of Oncology,University of Alberta,Cross Cancer Institute,Edmonton,Alberta T6G 2E1,Canada

来源：

World Journal of Gastroenterology | 2015年 / 21卷 / 04期

关键词：

Hyperhomocysteinemia; Colorectal cancer; Inflammatory bowel disease;

D O I：

暂无

中图分类号：

R735.34 [];

学科分类号：

100214 ;

摘要：

Homocysteine is an amino acid generated metabolically by the S-adenosylmethionine-dependent transmethylation pathway. In addition to being a well-known independent risk factor for coronary heart disease, is also a risk factor for cancer. Patients suffering from inflammatory bowel diseases(IBD) including ulcerative colitis and Crohn’s disease are at increased risk of developing colorectal cancer in comparison to healthy individuals. Furthermore, the risk of hyperhomocysteinaemia is significantly higher in IBD patients when compared with controls. In the present article, we review the mechanisms in which hyperhomocysteinemia may contribute to increased risk of colorectal cancer in IBD patients.

引用

页码：1081 / 1090

页数：10

共 32 条

[1] Colorectal cancer in patients with inflammatory bowel disease:Can we predict risk?
Vibeke Andersen
Jonas Halfvarson
Ulla Vogel
[J]. World Journal of Gastroenterology, 2012, (31) : 4091 - 4094
[2] Colorectal cancer in inflammatory bowel disease:What is the real magnitude of the risk?
Jessica K Dyson
Matthew D Rutter
[J]. World Journal of Gastroenterology, 2012, (29) : 3839 - 3848
[3] Etiology of inflammatory bowel disease:A unified hypothesis
Xiaofa Qin
[J]. World Journal of Gastroenterology, 2012, (15) : 1708 - 1722
[4] Colorectal cancer surveillance in patients with inflammatory bowel disease: What’s new?[J]. Danila Guagnozzi,Alfredo J Lucendo.World Journal of Gastrointestinal Endoscopy. 2012(04)
[5] Total plasma homocysteine and methylenetetrahydrofolate reductase C677T polymorphism in patients with colorectal carcinoma[J]. Sandra Battistelli,Aurelio Vittoria,Massimo Stefanoni,Camilla Bing,Franco Roviello.World Journal of Gastroenterology. 2006(38)
[6] High homocysteine is associated with increased risk of colorectal cancer independently of oxidative stress and antioxidant capacities[J] . Feng-Fan Chiang,Hwei-Ming Wang,Yu-Chun Lan,Min-Hsiu Yang,Shih-Chien Huang,Yi-Chia Huang.Clinical Nutrition . 2013
[7] Association of methylenetetrahydrofolate reductase C677T and A1298Cpolymorphisms with colorectal cancer risk: A meta?analysis[J] . Mengmeng Zhao,Xuelian Li,Chengzhong Xing,Baosen Zhou.Biomedical Reports . 2013 (5)
[8] Methylenetetrahydrofolate reductase C677T gene polymorphism and colorectalcancer risk: A case-control study[J] . Guancheng Yin,Hanxin Ming,Xiao Zheng,Yi Xuan,Jianwei Liang,Xing Jin.Oncology Letters . 2012 (2)
[9] Incidence and Mortality of Colorectal Adenocarcinoma in Persons With Inflammatory Bowel Disease From 1998 to 2010[J] . Lisa J. Herrinton,Liyan Liu,Theodore R. Levin,James E. Allison,James D. Lewis,Fernando Velayos.Gastroenterology . 2012 (2)
[10] Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review[J] . Natalie A. Molodecky,Ing Shian Soon,Doreen M. Rabi,William A. Ghali,Mollie Ferris,Greg Chernoff,Eric I. Benchimol,Remo Panaccione,Subrata Ghosh,Herman W. Barkema,Gilaad G. Kaplan.Gastroenterology . 2012 (1)

← 1 2 3 4 →